KRAS inhibitors MRTX1133 or daraxonrasib synergize with anti-CTLA4 in pancreatic cancer
A new viral-science report highlights fresh evidence that directly targeting oncogenic KRAS can prime the immune system to fight pancreatic ...
A new viral-science report highlights fresh evidence that directly targeting oncogenic KRAS can prime the immune system to fight pancreatic ...
Tertiary lymphoid structures (TLSs)—immune-cell aggregates that form in many solid tumours—have been linked to better outcomes from immune checkpoint blockade. ...
In a groundbreaking advancement poised to redefine the therapeutic landscape for cervical squamous carcinoma, researchers have unveiled compelling results from ...
In recent years, immune checkpoint blockade (ICB) has revolutionized the treatment landscape for various malignancies, marking a new era in ...
In a pioneering advancement that could reshape the therapeutic landscape for operable mesothelioma, researchers at the Johns Hopkins Kimmel Cancer ...
In a groundbreaking study poised to redefine therapeutic strategies for colorectal cancer, researchers have identified a novel molecular axis that ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine